alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 99.1**

**CERTIFICATION (Pursuant to 18 U.S.C. Section 1350)**

          The undersigned hereby certifies that, to his knowledge (i) the Form 10-Q filed by ECB Bancorp, Inc. (the “Issuer”) for the quarter endedMarch 31, 2003, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in that report fairly presents, in all material respects, the financial condition and resultsof operations of the Issuer on the dates and for the periods presented therein.

| Date: 5-12-03 |   |   |                                                      |
|---------------|--------|--------|-----------------------------------------------------------|
|          |   |   | /s/ ARTHUR H. KEENEY, III****                             |
|          |   |   | **Arthur H. Keeney, III (President & CEO)**           |
|          |   |   |                                                      |
| Date: 5-12-03 |   |   |                                                      |
|          |   |   | /s/  GARY M. ADAMS**    **       |
|          |   |   | **Gary M. Adams (Senior Vice President  & CFO)** |

22
ID Descriptor L* a* b* c h dL* da* db* dEcmc*

Standard 3923 STANDARD 44.54 1.68 15.05

Tolerance

1 3923A RED LIMIT 47.33 1.85 15.14 2.79 0.17 0.09 1.42

2 3923B FULL BLUE 

LIMIT 43.73 1.52 14.64 -0.81 -0.16 -0.41 0.53

3

4

5

6

7

8

9

Shade Number TAN 499 Piece/Roll Number 3923

DLA/ARMY SHADE TOLERANCE PROJECT March 21, 2018

Fabric Nomenclature JACKET, FLEECE, COLD WEATHER, 

ECWCS GL/PD 06-03A

COMMENTS: NUMBERS ARE FOR REFERENCE ONLY 

Equipment Type HUNTER ULTRA SCAN PRO Setting Mode: Specular Included - 

Reflectance

UV Filter – OUT UV Lamp OFF
Exhibit 12
 EL PASO CORPORATION
 COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDENDS
(DOLLARS IN MILLIONS)
 For the Three Months ended
March 31,2009
    
    
    2008EarningsIncome (loss) before income taxes
    
    $
    (1,483
    )
    
    $
    376Income from equity investees
    
    
    (19
    )
    
    
    (37
    )Income
(loss) before income taxes and before
adjustment for income from equity investees
    
    
    (1,502
    )
    
    
    339Fixed charges
    
    
    266
    
    
    
    248Distributed income of equity investees
    
    
    16
    
    
    
    60Capitalized interest
    
    
    (8
    )
    
    
    (12
    )Total earnings available for fixed charges
    
    $
    (1,228
    )
    
    $
    635Fixed chargesInterest and debt expense
    
    $
    263
    
    
    $
    245Interest component of rent
    
    
    3
    
    
    
    3Total fixed charges
    
    $
    266
    
    
    $
    248Ratio of earnings to fixed charges(1)
    
    
    
    
    
    
    2.56Fixed chargesInterest and debt expense
    
    $
    263
    
    
    $
    245Interest component of rent
    
    
    3
    
    
    
    3Preferred stock dividend of parent
    
    
    9
    
    
    
    32Total fixed charges and preferred stock dividend
    
    $
    275
    
    
    $
    280Ratio of earnings to combined fixed charges and preferred stock dividends(2)
    
    
    
    
    
    
    2.27
 
 (1)
    
    Earnings for the quarter ended March 31, 2009 were inadequate to cover fixed
charges by $1.5 billion.(2)
    
    Earnings for the quarter ended March 31, 2009 were inadequate to cover fixed
charges and preferred stock dividends by $1.5 billion.  
    
    income or loss from equity investees, adjusted to reflect actual distributions from equity
investments; and
    
    fixed charges;
  
    
    capitalized interest
  
    
    interest costs, not including interest on tax liabilities which is included in income tax
expense our income statement
    
    amortization of debt costs
    
    that portion of rental expense which we believe represents an interest factor; and
    
    preferred stock dividends.
[Federal Register Volume 63, Number 18 (Wednesday, January 28, 1998)]
[Notices]
[Page 4269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-1998]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-5:15 p.m., February 11, 1998; 8:30 
a.m.-1:15 p.m., February 12, 1998.
    Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: Agenda items will include updates from 
the National Center for Infectious Diseases; the National 
Immunization Program; the Vaccine Injury Compensation Program; the 
National Vaccine Program; update on influenza A(H5N1): epidemiologic 
and virologic surveillance and present status of vaccine 
development; update on influenza surveillance--U.S. and worldwide; 
influenza vaccination and Guillain Barre syndrome: update and 
proposed changes to ACIP recommendations; proposed changes to the 
1998-1999 ACIP recommendations for prevention and control of 
influenza; immunization of bone marrow transplant recipients 
recommendations on the use of Rotashield<SUP></SUP> (rotavirus 
vaccine) as part of the routine childhood immunization schedule; 
report of work group on computerization of ACIP recommendations; 
ACIP combination vaccines recommendation; comprehensive resolutions 
for the Vaccines for Children (VFC) Program; vaccine identification 
standards initiative; and alopecia associated with hepatitis B 
vaccination. Other matters of relevance among the committee's 
objectives may be discussed.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, CDC, 1600 Clifton Road, NE, M/S D-50, 
Atlanta, Georgia 30333, telephone 404/639-7250.

    Dated: January 21, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 98-1998 Filed 1-27-98; 8:45 am]
BILLING CODE 4163-18-P
<PAGE>   1

                                                                      EXHIBIT 23

                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

As independent public accountants, we hereby consent to the incorporation of our
reports included in this Form 10-K, into the Company's previously filed
Registration Statements:

<TABLE>
<CAPTION>

FORM              REGISTRATION NO.     PERTAINING TO JO-ANN STORES, INC.
----              ----------------     ---------------------------------
<S>              <C>                  <C>
S-4               333-80763            10 3/8% Senior Subordinated notes Due 2007
S-8               333-10093            1994 Executive Incentive Plan
S-8               33-72445             1998 Incentive Compensation Plan
S-8               33-32809             Employee Savings and Profit Sharing Plan
S-8               33-37355             1990 Employees Stock Option and Stock Appreciation Rights Plan
S-8               33-49690             1990 Employees Stock Option and Stock Appreciation Rights Plan
S-8               333-10087            1990 Employees Stock Option and Stock Appreciation Rights Plan
S-8               333-10091            1996 Stock Option Plan for Non-Employee Directors
S-8               333-55278            Nonqualified Stock Option Awards to Certain Employees
S-8               333-55280            Jo-Ann Stores, Inc. Savings Plan 401(k)

</TABLE>

Arthur Andersen LLP
Cleveland, Ohio,
May 3, 2001.



                                       97
EXHIBIT 32.2
                                  CERTIFICATION

                       Pursuant to 18 U.S.C. Section 1350,
                             As Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002


     In  connection  with  this  quarterly  report  on Form  10-QSB  of State of
Franklin Bancshares,  Inc., I, Charles E. Allen, Jr., Chief Executive Officer of
State of  Franklin  Bancshares,  Inc.,  certify,  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:



1.   The report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

2.   The information  contained in this report fairly presents,  in all material
     respects,  the  financial  condition  and results of operations of State of
     Franklin Bancshares, Inc.



Date:  August 9, 2005                      /s/Charles E. Allen, Jr.
                                           -------------------------------------
                                           Charles E. Allen, Jr.
                                           Chief Executive Officer (Principal
                                           Accounting and Financial Officer)
July 7, 2016

JUDGMENT

The Fourteenth Court of Appeals

KAREN KRISTINE SILVIO, Appellant

NO. 14-16-00252-CV V.

THE WINDSOR AUCTION COMPANY, Appellee

________________________________

Today the Court heard its own motion to dismiss the appeal from the 

judgment signed by the court below on February 2, 2016. Having considered the 

motion and found it meritorious, we order the appeal DISMISSED.

We further order that all costs incurred by reason of this appeal be paid by 

appellant, Karen Kristine Silvio.

We further order this decision certified below for observance.
No. 11-6184.

#### Juan Antonio Ledesma, Petitioner v. United States.

565 U.S. 956, 132 S. Ct. 432,

181 L. Ed. 2d 281,

2011 U.S. LEXIS 7220.

October 11, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 643 F.3d 384.
Form of Amendment of Form of Employment Agreement - Clegg, Weidenkopf, Dick



 Exhibit 10.6.1 
 Amendment of Form of Employment Agreement 
 Mr.
[                    ] (the “Executive”) and Aleris International, Inc. (the “Company”) and for certain purposes Aleris
Corporation (the “Parent”) formerly Aleris Holding Company entered into an agreement dated June 1, 2010. 
 The
Executive, Company and Parent desire to amend the Agreement effective immediately prior to the effectiveness of an initial public offering of Parent pursuant to the Form S-1 filed with the Securities and Exchange Commission on April 26, 2011,
as amended, as follows: 
 1. Clause (ii) of the first sentence of Section 3 is amended by replacing the words
“six (6) months” with “thirty (30) days”. 
 2. The last sentences of Section 5(a)(ii) and
(d) shall be amended to add at the end thereof the following: 
 ;provided, further, however, notwithstanding the foregoing,
if termination of employment is in anticipation of or within twelve (12) months following a Change of Control (as defined in the Aleris Corporation 2012 Equity Incentive Plan), the Severance Payment will be paid in a cash lump sum within thirty
(30) days following the Date of Termination, to the extent permissible under the rules regarding a “short term deferral” within the meaning of Treasury Regulations Section 1.409A-1(b)(4) of the Code and “separation pay
plans” within the meaning of Treasury Regulations Section 1.409A-1(b)(9) of the Code or otherwise not subject Executive to taxes under Section 409A of the Code. For purposes of the foregoing, a termination of employment will be deemed
to be “in anticipation of” a Change of Control if such termination is for the principal purpose of avoiding or evading the Company’s or Parent’s compensation obligations that would arise upon a termination following a Change of
Control.” 
 3. Section 5(d) is amended by replacing the words “twelve (12)” with “eighteen (18)”
in the two places it appears and to add after “(ii)” the following “the product of (x) one and one-half times (y)”. 
 4. Except as expressly amended by this letter agreement, the Agreement shall otherwise continue in full force and effect. 







 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written
above. 
  

			
	Executive
	
	 
	Name
	
	Aleris International, Inc.
		
	By:	 	 
		 	Title:
	
	Aleris Corporation
		
	By:	 	 
		 	Title:



  
 2
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-6445

RONALD JERRY SAWYER,

Plaintiff - Appellant,

versus

RON ANGELONE; COLIN ANGLICKER; LIEUTENANT

JOHNSON; CAPTAIN FERGUSON; LIEUTENANT HALL;

CAPTAIN HALL; BOB STAMPER; HERMAN L. WYNN; ISA

OHARA; CORRECTIONAL CONNER; OFFICER THOMAS;

OFFICER SLATE; CAPTAIN DAY; LIEUTENANT

SPROUSE; L. SAUNDERS; SERGEANT BRAXTON; SERGEANT WINDELL; SERGEANT STONE; OFFICER HAHN;

OFFICER CARTER; OFFICER RINGOLD; OFFICER

SPROUSE; H. D. GOULDIN; MAJOR BOYCE; CAPTAIN

BRUCE; CAPTAIN R. STARKS; R. SMITH, Captain;

OFFICER LIPSCONE; LIEUTENANT ROGERS; FRED

GREENE; WAYNE KINCAID; OFFICER MCDUFFY; G. D.

JOHNSON, Major,

Defendants - Appellees.

Appeal from the United States District Court for the Western District of Virginia, at Roanoke. Samuel G. Wilson, District Judge.

(CA-95-1392-R)

Submitted: August 15, 1996 Decided: August 20, 1996

Before MURNAGHAN and ERVIN, Circuit Judges, and BUTZNER, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.
2

Ronald Jerry Sawyer, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).

PER CURIAM:

Appellant appeals from the district court's order denying his

motion to alter or amend the judgment dismissing his 42 U.S.C. §

1983 (1988) action as frivolous. We have reviewed the record and

the district court's opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Sawyer v.

Angelone, No. CA-95-1392-R (W.D. VA. Feb. 13, 1996). We dispense

with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument

would not aid the decisional process.

AFFIRMED
No. 09-8253.

#### Mark W. Wiles, Petitioner v. Margaret Bagley, Warden.

562 U.S. 1199, 131 S. Ct. 1042,

178 L. Ed. 2d 863,

2011 U.S. LEXIS 984.

January 24, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.

Same case below, 561 F.3d 636.
Michigan Supreme Court

Lansing, Michigan

Marilyn Kelly,

 Chief Justice

Michael F. Cavanagh

Elizabeth A. Weaver

Maura D. Corrigan

Robert P. Young, Jr.

Stephen J. Markman

Diane M. Hathaway, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

July 26, 2010 

0719 

Order 

 

July 26, 2010 

140890 

PEOPLE OF THE STATE OF MICHIGAN, 

Plaintiff-Appellee, 

v SC: 140890 

 COA: 295874 

Berrien CC: 2008-405734-FC 

JOSHUA ALAN COLLINS, 

Defendant-Appellant. 

_________________________________________/ 

 On order of the Court, the application for leave to appeal the February 12, 2010 

order of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
109

Section C: Recommended Funding Levels, by State

New Mexico

Program Intervention Budgets: 2014

Recommended Annual Investment $22.8 million

Deaths in State Caused by Smoking

Annual average smoking-attributable deaths 2,600

Youth aged 0-17 projected to die from smoking 39,800

Annual Costs Incurred in State from Smoking

Total medical $844 million

State Revenue from Tobacco Sales and Settlement

FY 2012 tobacco tax revenue $99.4 million

FY 2012 tobacco settlement payment $39.3 million

Total state revenue from tobacco sales and settlement $138.7 million

Percent Tobacco Revenue to Fund at Recommended Level 16%

Annual Total (Millions) Annual Per Capita

Minimum Recommended Minimum Recommended

I. State and Community Interventions 

Multiple social resources working together will 

have the greatest long-term population impact.

$7.4 $9.3 $3.55 $4.46

II. Mass-Reach Health Communication Interventions 

Media interventions work to prevent smoking initiation, 

promote cessation, and shape social norms.

$1.3 $1.8 $0.62 $0.86

III. Cessation Interventions 

Tobacco use treatment is effective and highly cost-effective. $5.5 $8.7 $2.64 $4.17

IV. Surveillance and Evaluation 

Publicly funded programs should be accountable and 

demonstrate effectiveness.

$1.4 $2.0 $0.68 $0.95

V. Infrastructure, Administration, and Management 

Complex, integrated programs require experienced 

staff to provide fiscal management, accountability, 

and coordination.

$0.7 $1.0 $0.34 $0.47

TOTAL $16.3 $22.8 $7.83 $10.91

Note: A justification for each program element and the rationale for the budget estimates are provided in Section A. The funding estimates presented are based on adjustments for changes in population and cost-of-living increases since Best Practices—2007 was published. The actual 

funding required for implementing programs will vary depending on state characteristics, such as prevalence of tobacco use, sociodemographic 

factors, and other factors. See Appendix E for data sources on deaths, costs, revenue, and state-specific factors. 

Centers for Disease Control and Prevention • Office on Smoking and Health

www.cdc.gov/tobacco • tobaccoinfo@cdc.gov • 1 (800) CDC-INFO or 1 (800) 232-4636 

2014
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                                          0000032284
<NAME>                                         Orion Diversified Technologies

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              APR-30-1999
<PERIOD-START>                                 MAY-01-1998
<PERIOD-END>                                   APR-30-1999
<CASH>                                              0
<SECURITIES>                                        0
<RECEIVABLES>                                       0
<ALLOWANCES>                                        0
<INVENTORY>                                         0
<CURRENT-ASSETS>                                    0
<PP&E>                                              0
<DEPRECIATION>                                      0
<TOTAL-ASSETS>                                      0
<CURRENT-LIABILITIES>                         129,812
<BONDS>                                             0
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                       18,469
<OTHER-SE>                                   (148,281)
<TOTAL-LIABILITY-AND-EQUITY>                        0
<SALES>                                             0
<TOTAL-REVENUES>                                    0
<CGS>                                               0
<TOTAL-COSTS>                                       0
<OTHER-EXPENSES>                                  400
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                                  0
<INCOME-PRETAX>                                  (400)
<INCOME-TAX>                                        0
<INCOME-CONTINUING>                                 0
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                     (400)
<EPS-BASIC>                                       .00
<EPS-DILUTED>                                     .00



</TABLE>
Field Name    				Length  
------------  				--------
MRC_3445				VAR/DLM(|)
PRT_SKLTN_CD_0368			VAR/DLM(|)
MRD_STATUS_CD_0816			VAR/DLM(|)	
MRC_USG_DESI_0847			VAR/DLM(|)
KEYWRD_MOD_ST_2033			VAR/DLM(|)
KEYWRD_GRP_CD_2034			VAR/DLM(|)
RQMT_RPY_INST_2648			VAR/DLM(|)
RQMT_STMT_3614				VAR/DLM(|)
FIIG_4065				VAR/DLM(|)
MODE_CD_4735 				VAR/DLM(|)
No. 11-6685.

#### Antuan Dicks, Petitioner v. United States.

565 U.S. 994, 132 S. Ct. 540,

181 L. Ed. 2d 378,

2011 U.S. LEXIS 7611.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
OSI-12.31.11_EX10.51






Exhibit 10.51










January 10, 2012


Dave Pace
Chief Resource Officer
OSI Restaurant Partners, LLC




Dear Dave:


This will evidence my agreement to hereby amend my employment agreement to provide that my bonus target will be 85% of base salary for fiscal year 2012 and all years thereafter.






	
	
	Very Truly Yours,

	/s/ Dirk Montgomery

	Dirk Montgomery
<PAGE> 1
                                                               EXHIBIT  21
                                                               -----------

                    Falcon Products, Inc. and Subsidiaries

                        SUBSIDIARIES OF THE COMPANY
                        ---------------------------

      The following are wholly-owned subsidiaries of the Company:  Kaydee
Metal Products Corporation; Falcon Mexican Holdings, Inc.; Falcon
International, E.U.R.L. (a French corporation); Falcon De Juarez, S.A. de
C.V., Fundiciones Tecnicas, S.A., and Falcon De Baja California, S.A. de C.V.
(Mexican corporations); and Falcon Mimon, a.s. (a Czech Republic
corporation).  Falcon Mimon is an 84%-owned subsidiary of the Company.
Letter Agreement with James A.C. McDermott



 Exhibit 10.20 

 
 



 
 March 28, 2012 
 James A. C. McDermott 
 Fulcrum BioEnergy, Inc. 

4900 Hopyard Road, Suite 220 
 Pleasanton,
California 94588 
 Dear Jim, 
 This
letter will confirm that, effective upon completion of the initial public offering of Fulcrum BioEnergy, Inc. (the “Company”), you shall be appointed as Executive Chairman of the Company’s Board of Directors (the
“Board”). In addition, for your services as Executive Chairman of the Board, you shall receive the following compensation, in lieu of the compensation set forth in the Company’s Director Compensation Policy: 

 

	 	1.	You will be entitled to receive an annual retainer of $250,000, which is equal to 50% of the current base salary of the Company’s chief executive officer, and
shall be adjusted proportionately in connection with any adjustments to the base salary of the chief executive officer. The annual retainer will be payable on a semi-monthly basis on the fifteenth day and last day of each month.


  

	 	2.	You will be entitled to receive an annual cash bonus pursuant to the Company’s Short-Term Incentive Plan, or such similar plan as may be adopted by the Board, on
the same terms and conditions as the Company’s chief executive officer. 

  

	 	3.	Subject to Board approval, you will be eligible to receive equity awards pursuant to the Company’s 2012 Omnibus Equity Incentive Plan, or such similar plan as may
be adopted by the Board, in an amount equal to 50% of the equity awards granted to the Company’s chief executive officer. 

  

	 	4.	You will be entitled to reimbursement from the Company for your reasonable travel (including airfare and ground transportation), lodging and meal expenses incident to
meetings of the Board or committees thereof or in connection with other Board related business. 

  

	
	Very truly yours,
	
	/s/ Nate Redmond
	
	 Nate Redmond
 Compensation
Committee
 Board of Directors of Fulcrum BioEnergy, Inc.



 Acknowledged and agreed: 
 /s/ James A. C. McDermott 
 James A. C. McDermott